Preventing Problems in Ecstasy Users: Reduce Use to Reduce Harm

REFERENCES

• Aguirre , N. , Barrionuevo , M. , Ramírez , M. J. , Del Río , J. and Lasheras , B. 1999 . Alpha-lipoic acid prevents 3,4-methylenedioxy-methamphetamine (MDMA)-induced neurotoxicity . Neuroreport , : 3675 – 80 .
   PubMed Web of Science ®Google Scholar
• Akram , G. and Galt , M. 1999 . A profile of harm-reduction practices and co-use of illicit and licit drugs amongst users of dance drugs . Drugs: Education, Prevention & Policy , 6 ( 2 ) : 215 – 25 .
   Web of Science ®Google Scholar
• Ayus , J. C. and Arieff , A. I. 1996 . Brain damage and postoperative hyponatremia: The role of gender . Neurology , 46 ( 2 ) : 23 – 8 .
   Web of Science ®Google Scholar
• Baggott , M. , Jerome , L. and Stuart , R. 2001 . 3,4-Methylenedioxy-methamphetamine (MDMA): A Review of the English-Language Medical and Scientific Literature. Sarasota, Florida : Multidisciplinary Association for Psychedelic Studies. .
   Google Scholar
• Baggott , M. , Heifets , B. , Jones , R. T. , Mendelson , J. , Sferios , E. and Zehnder , J. 2000 . Chemical analysis of Ecstasy pills . Journal of the American Medical Association , 284 ( 17 ) : 2190
   PubMed Web of Science ®Google Scholar
• Battaglia , G. , Yeh , S. Y. and De Souza , E. B. 1988 . MDMA-induced neurotoxicity: Parameters of degeneration and recovery of brain serotonin neurons . Pharmacology, Biochemistry and Behavior , 29 ( 2 ) : 269 – 74 .
   PubMed Web of Science ®Google Scholar
• Bilsky , E. J. , Hui , Y. Z. , Hubbell , C. L. and Reid , L. D. 1990 . Methylenedioxy-methamphetamine's capacity to establish place preferences and modify intake of an alcoholic beverage . Pharmacology, Biochemistry and Behavior , 37 ( 4 ) : 633 – 38 .
   PubMed Web of Science ®Google Scholar
• Blanchard , J. , Tozer , T. N. and Rowland , M. 1997 . Pharmacokinetic perspectives on megadoses of ascorbic acid . American Journal of Clinical Nutrition , 66 ( 5 ) : 1165 – 71 .
   PubMed Web of Science ®Google Scholar
• Bolla , K. I. , Rothman , R. and Cadet , J. L. 1999 . Dose-related neurobehavioral effects of chronic cocaine use . Journal of Neuropsychiatry Clinical Neurosciences , 11 ( 3 ) : 361 – 69 .
   PubMed Web of Science ®Google Scholar
• Bolla , K. I. , McCann , U. D. and Ricaurte , G. A. 1998 . Memory impairment in abstinent MDMA (“Ecstasy”) users . Neurology , 51 ( 6 ) : 1532 – 37 .
   PubMed Web of Science ®Google Scholar
• Boys , A. , Marsden , J. , Griffiths , P. , Fountain , J. , Stillwell , G. and Strang , J. 1999 . Substance use among young people: The relationship between perceived functions and intentions . Addiction , 94 ( 7 ) : 1043 – 50 .
   PubMed Web of Science ®Google Scholar
• Broening , H. W. , Morford , L. L. , Inman-Wood , S. L. , Fukumura , M. and Vorhees , C. V. 2001 . 3,4-Methylenedioxymethamphetamine (Ecstasy)-induced learning and memory impairments depend on the age of exposure during early development . Journal of Neurosciences , 21 ( 9 ) : 3228 – 35 .
   PubMed Web of Science ®Google Scholar
• Broening , H. W. , Bowyer , J. F. and Slikker , W. Jr. 1995 . Age-dependent sensitivity of rats to the long-term effects of the serotonergic neurotoxicant (+/-)-3,4-methylenedioxymethamphetamine (MDMA) correlates with the magnitude of the MDMA-induced thermal response . Journal of Pharmacology and Experimental Therapeutics , 275 ( 1 ) : 325 – 33 .
   PubMed Web of Science ®Google Scholar
• Brown , C. and Osterloh , J. 1987 . Multiple severe complications from recreational ingestion of MDMA (“Ecstasy”) . Journal of the American Medical Association , 258 ( 6 ) : 780 – 81 .
   Web of Science ®Google Scholar
• Buchert , R. , Obrocki , J. , Thomasius , R. , Vaterlein , O. , Petersen , K. , Jenicke , L. , Bohuslavizki , K. H. and Clausen , M. 2001 . Long-term effects of “Ecstasy” abuse on the human brain studied by FDG PET . Nuclear Medicine Communications , 22 ( 8 ) : 889 – 97 .
   PubMed Web of Science ®Google Scholar
• Buck , A. , Gucker , P. M. , Schonbachler , R. D. , Arigoni , M. , Kneifel , S. , Vollenweider , F. X. , Aretamey , S. M. and Burger , C. 2000 . Evaluation of serotonergic transporters using PET and [11C](+)McN-5652: Assessment of methods . Journal of Cerebral Blood Flow and Metabolism , 20 ( 2 ) : 253 – 62 .
   PubMed Web of Science ®Google Scholar
• Byard , R. W. , Gilben , J. , James , R. and Lokan , R. J. 1998 . Amphetamine derivative fatalities in South Australia—is “Ecstasy” the culprit? Ar . Journal of Forensic Medicine and Pathology , 19 ( 3 ) : 261.5
   PubMed Web of Science ®Google Scholar
• Calafat , A. , Fernandez , C. , Juan , M. , Bellis , M. , Bohm , K. , Hakkarainen , P. , Kilfoyle-Carrington , M. , Kokkevi , A. , Maalsté , N. , Mendes , F. , Siamou , I. , Simon , J. , Stocco , P. and Zavatti , P. 2001 . Risk and Control in the Recreational Drug Culture. Palma de Mallorca : IREFREA and European Commission. .
   Google Scholar
• Calafat , A. , Stocco , P. , Mendes , F. , Simon , J. , van de Wijngaart , G. , Sureda , M. , Palmer , A. , Maalsté , N. and Zavatti , P. 1999 . Characteristics and Social Representation of Ecstasy in Europe. Palma de Mallorca : IREFREA and European Commission. .
   Google Scholar
• Cami , J. , Farré , M. , Mas , M. , Roset , P. N. , Poudevida , S. , Mas , A. , San , L. and de la Torre , R. 2000 . Human pharmacology of 3, 4-methylenedioxymethamphetamine (“Ecstasy”): Psychomotor performance and subjective effects . Journal of Clinical Psychopharmacology , 20 ( 4 ) : 455 – 66 .
   PubMed Web of Science ®Google Scholar
• Chang , L. , Grob , C. S. , Ernst , T. , Itti , L. , Mishkin , F. S. , Jose-Melchor , R. and Poland , R. E. 2000 . Effect of Ecstasy [3,4-methylenedioxymethamphetamine (MDMA)] on cerebral blood flow: A co-registered SPECT and MRI study . 98 ( 1 ) : 15 – 28 .
   Google Scholar
• Chang , L. , Ernst , T. , Grob , C. S. and Poland , R. E. 1999 . Cerebral 1H MRS alterations in recreational 3, 4-methylenedioxymethamphetamine (MDMA, “Ecstasy”) users . Journal of Magnetic Resonance Imaging , 10 ( 4 ) : 521 – 26 .
   PubMed Web of Science ®Google Scholar
• Cohen , R. S. 1995 . Subjective reports on the effects of the MMA(‘Ecstasy’) experience in humans . Progress in Neuropsychopharmacology & Biological Psychiatry , 19 ( 7 ) : 1137 – 45 .
   PubMed Web of Science ®Google Scholar
• Colado , M. I. and Green , A. R. 1995 . The spin trap reagent alpha-phenyl-N-ten-butyl nitrone prevents “Ecstasy”-induced neurodegeneration of 5-hydroxytryptamine neurones . European Journal of Pha nnacology , 280 ( 3 ) : 343 – 46 .
   PubMed Web of Science ®Google Scholar
• Colado , M. I. , Murray , T. K. and Green , A. R. 1993 . 5-HT loss in rat brain following 3,4-methylenedioxymethamphetamine (MDMA), pchloroamphetamine and fenfluramine administration and effects of chlormethiazole and dizocilpine . British Journal of Pharmacology , 108 ( 3 ) : 583 – 89 .
   PubMed Web of Science ®Google Scholar
• Cottier , L. B. , Womack , S. B. , Compton , W. M. and Ben-Abdallah , A. 2001 . Ecstasy abuse and dependence among adolescents and young adults: applicability and reliability of DSM-IV criteria . Human Psychophannacology: Clinical and Experimental , 16 ( 8 ) : 599 – 606 .
   PubMed Web of Science ®Google Scholar
• Croft , R. J. , Klugman , A. , Baldeweg , T. and Gruzelier , J. H. 2001a . Electrophysiological evidence of serotonergic impairment in long-term MDMA (“Ecstasy”) users . American Journal of Psychiatry , 158 ( 10 ) : 1687 – 92 .
   PubMed Web of Science ®Google Scholar
• Croft , R. J. , Mackay , A. J. , Mills , A. T. and Gruzelier , J. G. 2001b . The relative contributions of Ecstasy and cannabis to cognitive impairment . Psychophannacology (Berlin) , 153 ( 3 ) : 373 – 79 .
   PubMed Web of Science ®Google Scholar
• Curran , H. V. 2000 . Is MDMA (“Ecstasy”) neurotoxic in humans? An overview of evidence and of methodological problems in research . Neuropsychobiology , 42 ( 1 ) : 34 – 41 .
   PubMed Web of Science ®Google Scholar
• Curran , H. V. and Travill , R. A. 1997 . Mood and cognitive effects of +/- 3,4-methylenedioxymethamphetamine (MDMA, “Ecstasy”): Week-end “high” followed by mid-week low . Addiction , 92 ( 7 ) : 821 – 31 .
   PubMed Web of Science ®Google Scholar
• Dafters , R. I. 1995 . Hyperthermia following MDMA administration in rats: Effects of ambient temperature, water consumption, and chronic dosing . Physiology & Behavior , 58 ( 5 ) : 877 – 82 .
   PubMed Web of Science ®Google Scholar
• Dafters , R. I. 1994 . Effect of ambient temperature on hyperthermia and hyperkinesis induced by 3,4-methylenedioxymethamphetamine (MDMA or “Ecstasy”) in rats . Psychophannacology (Berlin) , 114 ( 3 ) : 505 – 8 .
   PubMed Web of Science ®Google Scholar
• Dafters , R. I. and Lynch , E. 1998 . Persistent loss of thermoregulation in the rat induced by 3,4-methylenedioxymethamphetamine (MDMA or “Ecstasy”) but not by fenfluramine . Psychopharmacology (Berlin) , 138 ( 2 ) : 207 – 12 .
   PubMed Web of Science ®Google Scholar
• Dafters , R. I. , Duffy , F. , O'Donnell , P. J. and Bouquet , C. 1999 . Level of use of 3,4-methylenedioxymethamphetamine (MDMA or Ecstasy) in humans correlates with EEG power and coherence . Psychophannacology (Berl) , 145 ( 1 ) : 82 – 90 .
   PubMed Web of Science ®Google Scholar
• Davis , W. M. and Borne , R. F. 1984 . Pharmacologic investigation of compounds related to 3,4- methylenedioxyamphetamine (MDA) . Substance and Alcohol Actions/Misuse , 5 ( 2 ) : 105 – 10 .
   PubMedGoogle Scholar
• Davison , D. and Parrott , A. C. 1997 . Ecstasy (MDMA) in recreational users: Self-reponed psychological and physiological effects . Human Psychopharmacology Clinical & Experimental , 12 ( 3 ) : 221 – 26 .
   Web of Science ®Google Scholar
• Daws , L. C. , Irvine , R. J. , Callaghan , P. O. , Toop , N. P. , White , J. M. and Bochner , F. 2000 . Differential behavioral and neurochemical effects of para- methoxyamphetamine and 3,4-methylenedioxymethamphetamine in the rat . Progress in Neuro-psychopharmacology & Biological Psychiatry , 24 ( 6 ) : 955 – 77 .
   PubMed Web of Science ®Google Scholar
• de la Torre , R. , Farré , M. , Ortuño , J. , Mas , M. , Brenneisen , R. , Rosel , P. N. , Segura , J. and Cami , J. 2000a . Non-linear pharmacokinetics of MDMA (“Ecstasy”) in humans . British Journal of Clinical Pharmacology , 49 ( 2 ) : 104 – 9 .
   PubMed Web of Science ®Google Scholar
• de la Torre , R. , Farré , M. , Roset , P. N. , Hernandez Lopez , C , Mas , M. , Ortuño , J. , Menoyo , E. , Pizarro , N. , Segura , J. and Cami , J. 2000b . Pharmacology of MDMA in humans . Annals of the New York Academy of Sciences , 914 : 225 – 37 .
   PubMed Web of Science ®Google Scholar
• De Letter , E. A. , Coopman , V. A. , Cordonnier , J. A. and Piette , M. H. 2001 . One fatal and seven non-fatal cases of 4-methylthioamphetamine (4-MTA) intoxication: Clinic-pathological findings . International Journal of Legal Medicine , 114 ( 6 ) : 352 – 56 .
   PubMed Web of Science ®Google Scholar
• Decaestecker , T. , De Letter , E. , Clauwaen , K. , Bouche , M. P. , Lambert , W. , Van Bocxlaer , J. , Piette , M. , Van den Eeckhout , E. , Van Peteghem , C. and De Leenheer , A. 2001 . Fatal 4-MTA intoxication: Development of a liquid chromatographic-tandem mass spectrometric assay for multiple matrices . Journal of Analytical Toxicology , 25 ( 8 ) : 705 – 10 .
   PubMed Web of Science ®Google Scholar
• Demirkiran , M. , Jankovic , J. and Dean , J. M. 1996 . Ecstasy intoxication: An overlap between serotonin syndrome and neuroleptic malignant syndrome . Clinical Neuropharmacology , 19 ( 2 ) : 157 – 64 .
   PubMed Web of Science ®Google Scholar
• European Monitoring Centre for Drugs and Drug Addiction . 2001a . An Inventory of On-Site Pill-Testing Interventions in the EU. Luxembourg : Office for Official Publications of the European Communities. .
   Google Scholar
• European Monitoring Centre for Drugs and Drug Addiction . 2001b . Report on the Risk Assessment of PMMA in the Framework of the Joint Action on New Synthetic Drugs. Luxembourg : Office for Official Publications of the European Communities. .
   Google Scholar
• European Monitoring Centre for Drugs and Drug Addiction . 1999 . Report on the Risk Assessment of 4-MTA in the Framework of the Joint Action on New Synthetic Drugs. Luxembourg : Office for Official Publications of the European Communities. .
   Google Scholar
• Felgate , H. E. , Felgate , P. O. , James , R. A. , Sims , D. N. and Vozzo , D. C. 1998 . Recent paramethoxyamphetamine deaths . Journal of Analytical Toxicology , 22 ( 2 ) : 169 – 72 .
   PubMed Web of Science ®Google Scholar
• Fischer , C. , Hatzidimitriou , G. , Wlos , J. , Katz , J. and Ricaune , G. 1995 . Reorganization of ascending 5-HT axon projections in animals previously exposed to the recreational drug (+/-)3,4- methylenedioxymethamphetamine (MDMA, “Ecstasy”) . Journal of Neuro science , 15 ( 8 ) : 5476 – 85 .
   Google Scholar
• Forsling , M. L. , Fallon , J. K. , Shah , D. , Tilbrook , G. S. , Cowan , D. A. , Kieran , A. T. and Hutt , A. J. 2002 . The effect of 3,4- methylenedioxymethamphetamine (MDMA, “Ecstasy”) and its metabolites on neurohypophysial hormone release from the isolated rat hypothalamus . British Journal of Pharmacology , 135 ( 3 ) : 649 – 56 .
   PubMed Web of Science ®Google Scholar
• Fox , H. C. , Parrott , A. C. and Turner , J. J. 2001 . Ecstasy use: cognitive deficits related to dosage rather than self- reponed problematic use of the drug . Journal of Psychopharmacology , 15 ( 4 ) : 273 – 81 .
   PubMed Web of Science ®Google Scholar
• Gamma , A. , Frei , E. , Lehmann , D. , Pascual-Marqui , R. D. , Hell , D. and Vollenweider , F. X. 2000 . Mood state and brain electric activity in Ecstasy users . Neuroreport , 11 ( 1 ) : 157 – 62 .
   PubMed Web of Science ®Google Scholar
• Gerra , G. , Zaimovic , A. , Ferri , M. , Zambelli , U. , Timpano , M. , Neri , E. , Marzocchi , G. F. , Delsignore , R. and Brambilla , F. 2000 . Long-lasting effects of (+/-)3,4-methylenedioxymethamphetamine (Ecstasy) on serotonin system function in humans . Biological Psychiatry , 41 ( 2 ) : 127 – 36 .
   Google Scholar
• Gerra , G. , Zaimovic , A. , Giucastro , G. , Maestri , D. , Monica , C , Sanori , R. , Caccavari , R. and Delsignore , R. 1998 . Serotonergic function after (+/-)3,4-methylene-dioxymethamphetamine (“Ecstasy”) in humans . International Clinical Psychopharmacology , 13 ( 1 ) : 1 – 9 .
   PubMed Web of Science ®Google Scholar
• Gordon , C. J. , Watkinson , W. P. , O'Callaghan , J. P. and Miller , D. B. 1991 . Effects of 3,4-methylenedioxymethamphetamine on autonomic thermoregulatory responses of the rat . Pharmacology, Biochemistry and Behavior , 38 ( 2 ) : 339 – 44 .
   PubMed Web of Science ®Google Scholar
• Gore , S. M. 1999 . Fatal uncertainty: death-rate from use of Ecstasy or heroin . Lancet , 354 ( 9186 ) : 1265 – 66 .
   PubMed Web of Science ®Google Scholar
• Gough , A. C. , Miles , J. S. , Spurr , N. K. , Moss , J. E. , Gaedigk , A. , Eichelbaum , M. and Wolf , C. R. 1990 . Identification of the primary gene defect at the cytochrome P450 CYP2D locus . Nature , 347 ( 6295 ) : 773 – 76 .
   PubMed Web of Science ®Google Scholar
• Gouzoulis-Mayfrank , E. , Daumann , J. , Tuchtenhagen , F. , Pelz , S. , Becker , S. , Kunert , H. J. , Fimm , B. and Sass , H. 2000 . Impaired cognitive performance in drug free users of recreational Ecstasy (MDMA) . Journal of Neurology, Neurosurgery, and Psychiatry , 6 ( 6 ) : 719 – 25 .
   Google Scholar
• Graumlich , J. F. , Ludden , T. M. , Conry-Cantilena , C , Cantilena , L. R. Jr. , Wang , Y. and Levine , M. 1997 . Pharmacokinetic model of ascorbic acid in healthy male volunteers during depletion and repletion . Pharmaceutical Research , 14 ( 9 ) : 1133 – 39 .
   PubMed Web of Science ®Google Scholar
• Gudelsky , G. A. , Yamamoto , B. K. and Nash , J. F. 1994 . Potentiation of 3,4- methylenedioxymethamphetamine-induced dopamine release and serotonin neurotoxicity by 5-HT2 receptor agonists . European Journal of Pharmacology , 264 ( 3 ) : 325 – 30 .
   PubMed Web of Science ®Google Scholar
• Hall , A. P. , Lyburn , I. D. , Spears , F. D. and Riley , B. 1996 . An uiusual case of Ecstasy poisoning . Intensive Care Medicine , 22 ( 7 ) : 670 – 71 .
   PubMed Web of Science ®Google Scholar
• Hammersley , R. , Khan , F. and Ditton , J. 2002 . Ecstasy and the Rise of the Chemical Generation. London : Routledge. .
   Google Scholar
• Hammersley , R. , Ditton , J. , Smith , I. and Short , E. 1999 . Patterns of Ecstasy use by drug users . British Journal of Criminology , 39 ( 4 ) : 625 – 47 .
   Web of Science ®Google Scholar
• Hansen , D. , Maycock , B. and Lower , T. 2001 . “Weddings, parties, anything …”, a qualitative analysis of Ecstasy use in Perth, Western Australia . International Journal of Drug Policy , 12 : 181 – 99 .
   PubMedGoogle Scholar
• Hatzidimitriou , G. , McCann , U. D. and Ricaurte , G. A. 1999 . Altered serotonin innervation patterns in the forebrain of monkeys treated with (+/-)3,4-methylenedioxymethamphetamine seven years previously: factors influencing abnormal recovery . Journal of Neuroscience , 19 ( 12 ) : 5096 – 107 .
   PubMed Web of Science ®Google Scholar
• Heffernan , T. M. , Jarvis , H. , Rodgers , J. , Scholey , A. B. and Ling , J. 2001 . Prospective memory, everyday cognitive failure and central executive function and recreational users of Ecstasy . Human Psychopharmacology: Clinical and Experimental , 16 ( 8 ) : 607 – 12 .
   PubMed Web of Science ®Google Scholar
• Heinz , A. and Jones , D. W. 2000 . Serotonin transporters in Ecstasy users . British Journal of Psychiatry , 176 : 193 – 95 .
   PubMed Web of Science ®Google Scholar
• Henry , J. A. 2000 . Metabolic consequences of drug misuse . British Journal of Anaesthesia , 85 ( 1 ) : 136 – 42 .
   PubMed Web of Science ®Google Scholar
• Henry , J. and Rella , J. 2001 . “ Medical risks associated with MDMA use. ” . In Ecstasy: The Complete Guide: A Comprehensive Look at the Risks and Benefits of MDMA. Edited by: Holland , J. Rochester, New York : Park Street Press. .
   Google Scholar
• Henry , J. A. , Fallon , J. K. , Kieran , A. T. , Hutt , A. J. , Cowan , D. A. and Forsling , M. 1998 . Low-dose MDMA (“Ecstasy”) induces vasopressin secretion . Lancet , 351 ( 9118 ) : 1784
   PubMed Web of Science ®Google Scholar
• Henry , J. A. , Jeffreys , K. J. and Dawling , S. 1992 . Toxicity and deaths from 3,4-methylenedioxymethamphetamine (“Ecstasy”) . Lancet , 340 ( 8816 ) : 384 – 87 .
   PubMed Web of Science ®Google Scholar
• Heming , R. I. , King , D. E. , Better , W. E. and Cadet , J. L. 1999 . Neurovascular deficits in cocaine abusers . Neuropsychopharmacology , 21 ( 1 ) : 110 – 18 .
   PubMed Web of Science ®Google Scholar
• Jansen , K. L. 1999 . Ecstasy (MDMA) dependence . Drug and Alcohol Dependence , 53 ( 2 ) : 121 – 4 .
   PubMed Web of Science ®Google Scholar
• Jenkins , P. 1999 . Synthetic Panics: The Symbolic Politics of Designer Drugs. New York : New York University Press. .
   Google Scholar
• Johnston , L. D. , O'Malley , P. M. and Bachman , J. G. 2001 . Monitoring the Future: National Survey Results on Drug Abuse, 1975–2000, Vol. 1. Secondary School Students. Bethesda, Maryland : National Institute on Drug Abuse. .
   Google Scholar
• Kish , S. J. 2002 . How strong is the evidence that brain serotonin neurons are damaged in human users of Ecstasy? . Pharmacology, Biochemistry, and Behavior , 71 ( 4 ) : 845 – 55 .
   PubMed Web of Science ®Google Scholar
• Kraner , J. C. , McCoy , D. J. , Evans , M. A. , Evans , L. E. and Sweeney , B. J. 2001 . Fatalities caused by the MDMA-related drug paramethoxyamphetamine (PMA) . Journal of Analytical Toxicology , 25 ( 7 ) : 645 – 48 .
   PubMed Web of Science ®Google Scholar
• Kreth , K. , Kovar , K. , Schwab , M. and Zanger , U. M. 2000 . Identification of the human cytochromes P450 involved in the oxidative metabolism of “Ecstasy”-related designer drugs . Biochemical Pharmacology , 59 ( 12 ) : 1563 – 71 .
   PubMed Web of Science ®Google Scholar
• Kuikka , J. T. and Ahonen , A. K. 1999 . Toxic effect of MDMA on brain serotonin neurons . Lancet , 353 ( 9160 ) : 1269 discussion 1270–71
   PubMedGoogle Scholar
• Lauerma , H. , Wuorela , M. and Halme , M. 1998 . Interaction of serotonin reuptake inhibitor and 3,4-methylenedioxymethamphetamine? . Biological Psychiatry , 43 ( 12 ) : 929
   PubMed Web of Science ®Google Scholar
• Liechti , M. E. , Gamma , A. and Vollenweider , F. X. 2001 . Gender differences in the subjective effects ofMDMA . Psychopharmacology , 154 ( 2 ) : 161 – 68 .
   PubMed Web of Science ®Google Scholar
• Liechti , M. E. and Vollenweider , F. X. 2000 . The serotonin uptake inhibitor citalopram reduces acute cardiovascular and vegetative effects of 3,4-methylenedioxymethamphetamine (“Ecstasy”) in healthy volunteers . Journal of Psychopharmacology , 14 ( 3 ) : 269 – 74 .
   PubMed Web of Science ®Google Scholar
• Liester , M. B. , Grob , C. S. , Bravo , G. L. and Walsh , R. N. 1992 . Phenomenology a sequelae of 3,4-methylenedioxymethamphetamine use . Journal of Nervous and Mental Disorders , 180 ( 6 ) : 345 – 52 . discussion 353–54
   PubMed Web of Science ®Google Scholar
• Ling , L. H. , Marchant , C. , Buckley , N. A. , Prior , M. and Irvine , R. J. 2001 . Poisoning with the recreational drug paramethoxyamphetamine (“death”) . Medical Journal of Australia , 174 ( 9 ) : 453 – 55 .
   PubMed Web of Science ®Google Scholar
• Logan , B. J. , Laverty , R. , Sanderson , W. D. and Yee , Y. B. 1988 . Differences between rats and mice in MDMA (methylenedioxymethylamphetamine) neurotoxicity . European Journal of Pharmacology , 152 ( 3 ) : 227 – 34 .
   PubMed Web of Science ®Google Scholar
• Maalsté , N. First aid in raves . Presentation at Club Health: the First International Conference on Night-Life, Substance Use and Related Health Issues . November 10–12 , Amsterdam. Accessed using world wide web on April 1, 2002 at http://www.clubhealth.org.uk/pages/2000.htm
   Google Scholar
• Malber , J. E. and Seiden , L. S. 1998 . Small changes in ambient temperature cause large changes in 3,4-methylenedioxymethamphetamine (MDMA)-induced serotonin neurotoxicity and core body temperature in the rat . Journal of Neuroscience , 18 ( 13 ) : 5086 – 94 .
   PubMed Web of Science ®Google Scholar
• Marston , H. M. , Reid , M. E. , Lawrence , J. A. , Olverman , H. J. and Butcher , S. P. 1999 . Behavioural analysis of the acute and chronic effects of MDMA treatment in the rat . Psychopharmacology (Berlin) , 144 ( 1 ) : 67 – 76 .
   PubMed Web of Science ®Google Scholar
• Martin , T. L. 2001 . Three cases of fatal paramethoxyamphetamine overdose . Journal of Analytical Toxicology , 25 ( 7 ) : 649 – 51 .
   PubMed Web of Science ®Google Scholar
• Marzuk , P. M. , Tardiff , K. , Leon , A. C. , Hirsch , C. S. , Portera , L. , Iqbal , M. I. , Nock , M. K. and Hartwell , N. 1998 . Ambient temperature and mortality from unintentional cocaine overdose . Journal of the American Medical Association , 279 ( 22 ) : 1795 – 800 .
   Web of Science ®Google Scholar
• Maurer , H. H. , Bickeboeller-Friedrich , J. , Kraemer , T. and Peters , F. T. 2000 . Toxicokinetics and analytical toxicology of amphetamine-derived designer drugs (“Ecstasy”) . Toxicology Letter , 112–113 : 133 – 42 .
   PubMed Web of Science ®Google Scholar
• Maxwell , D. L. , Polkey , M. I. and Henry , J. A. 1993 . Hyponatremia and catatonic stupor after taking “Ecstasy.” . British Medical Journal , 307 ( 6916 ) : 1399
   PubMed Web of Science ®Google Scholar
• McBean , D. E. , Sharkey , J. , Ritchie , I. M. and Kelly , P. A. 1990 . Evidence for a possible role for serotonergic systems in the control of cerebral blood flow . Brain Research , 537 ( 1–2 ) : 307 – 10 .
   PubMed Web of Science ®Google Scholar
• McCann , U. D. and Ricaurte , G. 2001 . Caveat emptor: Editors beware . Neuropsychopharmacology , 24 ( 3 ) : 333 – 334 .
   PubMed Web of Science ®Google Scholar
• McCann , U. D. , Eligulashvili , V. , Mertl , M. , Murphy , D. L. and Ricaurte , G. A. 1999a . Altered neuroendocrine and behavioral responses to mchlorophenylpiperazine in 3,4-methylenedioxymethamphetamine (MDMA) users . Psychopharmacology (Berlin) , 147 ( 1 ) : 56 – 65 .
   PubMed Web of Science ®Google Scholar
• McCann , U. D. , Mertl , M. , Eligulashvili , V. and Ricaurte , G. A. 1999b . Cognitive performance in (+/-)3,4-methylenedioxymethamphetamine (MDMA, “Ecstasy”) users: a controlled study . Psychopharmacology (Berlin) , 143 ( 4 ) : 417 – 25 .
   PubMed Web of Science ®Google Scholar
• McCann , U. D. , Szabo , Z. , Scheffel , U. , Dannals , R. F. and Ricaurte , G. A. 1998 . Positron emission tomographic evidence of toxic effect of MDMA (“Ecstasy”) on brain serotonin neurons in human beings . Lancet , 352 ( 9138 ) : 1433 – 37 .
   PubMed Web of Science ®Google Scholar
• McCann , U. D. , Ridenour , A. , Shaham , Y. and Ricaurte , G. A. 1994 . Serotonin neurotoxicity after (+/-)3,4-methylenedioxymethamphetamine (MDMA; “Ecstasy”): A controlled study in humans . Neuropsychopharmacology , 10 ( 2 ) : 129 – 38 .
   PubMed Web of Science ®Google Scholar
• Measham , F. , Aldridge , J. and Parker , H. 2001 . Dancing on Drugs: Risks, Health and Hedonism in the British Club Scene. London : Free Association Books. .
   Google Scholar
• Mechan , A. O. , Moran , P. M. , Elliott , M. , Young , A. J. , Joseph , M. H. and Green , R. 2002 . A study of the effect of a single neurotoxic dose of 3,4- methylenedioxymethamphetamine (MDMA; “Ecstasy”) on the subsequent long- term behaviour of rats in the plus maze and open field . Psychopharmacology (Berlin) , 159 ( 2 ) : 167 – 75 .
   PubMed Web of Science ®Google Scholar
• Mechan , A. O. , O'shea , E. , Elliott , J. M. , Colado , M. I. and Green , A. R. 2001 . A neurotoxic dose of 3,4-methylenedioxymethamphetamine (MDMA; Ecstasy) to rats results in a long term defect in thermoregulation . Psychopharmacology (Berlin) , on-line publication (DOI 10.1007/s002130100735)
   Web of Science ®Google Scholar
• Melega , W. P. , Lacan , G. , Harvey , D. C. , Huang , S. C. and Phelps , M. E. 1998 . Dizocilpine and reduced body temperature do not prevent methamphetamine-induced neurotoxicity in the vervet monkey: [11 C]WIN 35,428-positron emission tomography studies . Neuroscience Letters , 258 ( 1 ) : 17 – 20 .
   PubMed Web of Science ®Google Scholar
• Meyer , V. 2000 . HPLC on the dance floor . Analytical Chemistry , 72 ( 23 ) : 735A – 736A .
   PubMed Web of Science ®Google Scholar
• Miller , D. B. and O'Callaghan , J. P. 1994 . Environment-, drug- and stress-induced alterations in body temperature affect the neurotoxicity of substituted amphetamines in the C57BL/6J mouse . Journal of Pharmacology and Experimental Therapies , 270 ( 2 ) : 752 – 60 .
   PubMed Web of Science ®Google Scholar
• Monks , T. J. , Ghersi-Egea , J. F. , Philbert , M. , Cooper , A. J. and Lock , E. A. 1999 . Symposium overview: the role of glutathione in neuroprotection and neurotoxicity . Toxicological Sciences , 51 ( 2 ) : 161 – 77 .
   PubMed Web of Science ®Google Scholar
• Mordenti , J. and Chappell , W. 1989 . “ The use of interspecies scaling in toxicokinetics. ” . In Toxicokinetics in New Drug Development. Edited by: Yacobi , A. , Kelly , J. and Batra , V. New York : Pergamon Press. .
   Google Scholar
• Morgan , M. J. 1999 . Memory deficits associated with recreational use of “Ecstasy” (MDMA) . Psychopharmacology (Berlin) , 141 ( 1 ) : 30 – 6 .
   PubMed Web of Science ®Google Scholar
• Morley , K. C. , Gallate , J. E. , Hunt , G. E. , Mallet , P. E. and McGregor , I. S. 2001 . Increased anxiety and impaired memory in rats 3 months after administration of 3,4-methylenedioxymethamphetamine (“Ecstasy”) . European Journal of Pharmacology , 433 ( 1 ) : 91 – 9 .
   PubMed Web of Science ®Google Scholar
• Newcombe , R. and Woods , S. How risky is Ecstasy? A model for comparing the mortality risks of Ecstasy use, dance parties and related activities . Presentation at Club Health: the First International Conference on Night-Life, Substance Use and Related Health Issues . November 10–12 , Amsterdam. Accessed using world wide web on April 1, 2002 at http://www.clubhealth.org.uk/pages/2000.htm
   Google Scholar
• Obergriesser , T. , Ende , G. , Braus , D. F. and Henn , F. A. 2001 . Hippocampal 1H-MRSI in Ecstasy users . European Archives of Psychiatry and Clinical Neuroscience , 251 ( 3 ) : 114 – 16 .
   PubMed Web of Science ®Google Scholar
• Obrocki , J. , Buchert , R. , Vaterlein , O. , Thomasius , R. , Beyer , W. and Schiemann , T. 1999 . Ecstasymdash;long-term effects on the human central nervous system revealed by positron emission tomography . British Journal of Psychiatry , 175 : 186 – 88 .
   PubMed Web of Science ®Google Scholar
• O'Donohoe , A. , O'Flynn , K. , Shields , K. , Hawi , Z. and Gill , M. 1998 . MDMA toxicity: no evidence for a major influence of metabolic genotype at CYP2D6 . Addiction Biology , 3 : 309 – 14 .
   PubMed Web of Science ®Google Scholar
• Office of Applied Studies/Drug Abuse Warning Network . 2001 . Weighted emergency department estimates for the coterminous U.S. by year: 1994- 2000 Available at http://www.samhsa.gov/oas/webOnly.htm
   Google Scholar
• O'Heam , E. , Battaglia , G. , De Souza , E. B. , Kuhar , M. J. and Molliver , M. E. 1988 . Methylenedioxyamphetamine (MDA) and methylenedioxymethamphetamine (MDMA) cause selective ablation of serotonergic axon terminals in forebrain: immunocytochemical evidence for neurotoxicity . Journal of Neurosciences , 8 ( 8 ) : 2788 – 803 .
   PubMed Web of Science ®Google Scholar
• O'shea , E. , Granados , R. , Esteban , B. , Colado , M. I. and Green , A. R. 1998 . The relationship between the degree of neurodegeneration of rat brain 5-HT nerve terminals and the dose and frequency of administration of MDMA (“Ecstasy”) . Neuropharmacology , 37 ( 7 ) : 919 – 26 .
   PubMed Web of Science ®Google Scholar
• Parker , H. , Aldridge , J. and Measham , F. 1998 . Illegal Leisure: The Normalization of Adolescent Recreational Drug Use. London : Routledge. .
   Google Scholar
• Parrot , A. C. 2001 . Human psychopharmacology of Ecstasy (MDMA): A review of 15 years of empirical research . Human Psychopharmacology: Clinical and Experimental , 16 ( 8 ) : 557 – 77 .
   PubMed Web of Science ®Google Scholar
• Parrott , A. C. and Lasky , J. 1998 . Ecstasy (MDMA) effects upon mood and cognition: Before, during and after a Saturday night dance . Psychopharmacology (Berlin) , 139 ( 3 ) : 261 – 68 .
   PubMed Web of Science ®Google Scholar
• Parrott , A. C. and Stuart , M. 1997 . Ecstacy (MDMA), amphetamine, and LSD: Comparative mood profiles in recreational polydrug users . Human Psychopharmacology: Clinical & Experimental , 12 ( 5 ) : 501 – 04 .
   Web of Science ®Google Scholar
• Pedersen , N. P. and Blessing , W. W. 2001 . Cutaneous vasoconstriction contributes to hyperthermia induced by 3,4- methylenedioxymethamphetamine (Ecstasy) in conscious rabbits . Journal of Neuroscience , 21 ( 21 ) : 8648 – 54 .
   PubMed Web of Science ®Google Scholar
• Peroutka , S. J. , Newman , H. and Harris , H. 1988 . Subjective effects of 3,4- methylenedioxymethamphetamine in recreational users . Neuropsychopharmacology , 1 ( 4 ) : 273 – 77 .
   PubMed Web of Science ®Google Scholar
• Peroutka , S. J. , Pascoe , N. and Faull , K. F. 1987 . Monoamine metabolites in the cerebrospinal fluid of recreational users of 3,4-methylenedioxymethamphetamine (MDMA; “Ecstasy”) . Research Communication in Substance Abuse , 8 ( 3–4 ) : 125 – 38 .
   Google Scholar
• Pope , H. G. Jr. and Yurgelun-Todd , D. 1996 . The residual cognitive effects of heavy marijuana use in college students . Journal of the American Medical Association , 275 ( 7 ) : 521 – 27 .
   PubMed Web of Science ®Google Scholar
• Price , L. H. , Ricaurte , G. A. , Krystal , J. H. and Heninger , G. R. 1989 . Neuroendocrine and mood responses to intravenous L-tryptophan in 3,4-methylenedioxymethamphetamine (MDMA) users. Preliminary observations . Archives of General Psychiatry , 46 ( 1 ) : 20 – 2 .
   PubMedGoogle Scholar
• Reneman , L. , Majoie , C. B. , Flick , H. and den Heeten , G. J. 2002 . Reduced N-acetylaspartate levels in the frontal cortex of 3,4-methylenedioxymethamphetamine (Ecstasy) users: Preliminary results . AJNR American Journal of Neuroradiology , 123 ( 2 ) : 231 – 37 .
   Google Scholar
• Reneman , L. , Booij , J. , de Bruin , K. , Reitsma , J. B. , de Wolff , F. A. , Gunning , W. B. , den Heeten , G. J. and vanden Brink , W. 2001a . Effects of dose, sex, and long-term abstention from use on toxic effects of MDMA (Ecstasy) on brain serotonin neurons . Lancet , 358 ( 9296 ) : 1864 – 69 .
   PubMed Web of Science ®Google Scholar
• Reneman , L. , Lavalaye , J. , Schmand , B. , de Wolff , F. A. , van den Brink , W. , den Heeten , G. J. and Booij , J. 2001b . Cortical serotonin transporter density and verbal memory in individuals who stopped using 3,4-methylenedioxymethamphetamine (MDMA or “Ecstasy”): Preliminary findings . Archives of General Psychiatry , 58 ( 10 ) : 901 – 06 .
   PubMed Web of Science ®Google Scholar
• Reneman , L. , Booij , J. , Schmand , B. , van den Brink , W. and Gunning , B. 2000a . Memory disturbances in “Ecstasy” users are correlated with an altered brain serotonin neurotransmission . Psychopharmacology (Berlin) , 148 ( 3 ) : 322 – 24 .
   PubMed Web of Science ®Google Scholar
• Reneman , L. , Habraken , J. B. , Majoie , C. B. , Booij , J. and den Heeten , G. J. 2000b . MDMA (“Ecstasy”) and its association with cerebrovascular accidents: Preliminary findings . AJNR American Journal of Neuroradiology , 21 ( 6 ) : 1001 – 07 .
   PubMed Web of Science ®Google Scholar
• Ricaurte , G. , Bryan , G. , Strauss , L. , Seiden , L. and Schuster , C. 1985 . Hallucinogenic amphetamine selectively destroys brain serotonin nerve terminals . Science , 229 ( 4717 ) : 986 – 88 .
   PubMed Web of Science ®Google Scholar
• Ricaurte , G. A. , Finnegan , K. T. , Irwin , I. and Langston , J. W. 1990 . Aminergic metabolites in cerebrospinal fluid of humans previously exposed to MDMA: preliminary observations . Annals of the New York Academy of Sciences , 600 : 699 – 708 . discussion 708–10
   PubMed Web of Science ®Google Scholar
• Ricaurte , G. A. , Forno , L. S. , Wilson , M. A. , DeLanney , L. E. , Irwin , I. , Molliver , M. E. and Langston , J. W. 1988 . (+/-)3,4-Methylenedioxy-methamphetamine selectively damages central serotonergic neurons in nonhuman primates . Journal of the American Medical Association , 260 ( 1 ) : 51 – 5 .
   Web of Science ®Google Scholar
• Riley , S. C. , James , C. , Gregory , D. , Dingle , H. and Cadger , M. 2001 . Patterns of recreational drug use at dance events in Edinburgh, Scotland . Addiction , 96 ( 7 ) : 1035 – 47 .
   PubMed Web of Science ®Google Scholar
• Rodgers , J. 2000 . Cognitive performance amongst recreational users of “Ecstasy.” . Psychopharmacology (Berlin) , 151 ( 1 ) : 19 – 24 .
   PubMed Web of Science ®Google Scholar
• Rodgers , J. , Buchanan , T. , Scholey , A. B. , Heffernan , T. M. , Ling , J. and Parrot , A. 2001 . Differential effects of Ecstasy and cannabis on self-reports of memory ability: A web-based study . Human Psychopharmacology: Clinical and Experimental , 16 ( 8 ) : 619 – 25 .
   PubMed Web of Science ®Google Scholar
• Saunders , N. 1993 . E is for Ecstasy: Accessed using world wide web on April 1 2002 at http://www.Ecstasy.org/books/e4x/
   Google Scholar
• Schifano , F. , Di Furia , L. , Forza , G. , Minicuci , N. and Bricolo , R. 1998 . MDMA (“Ecstasy”) consumption in the context of polydrug abuse: A report on 150 patients . Drug and Alcohol Dependency , 52 ( 1 ) : 85 – 90 .
   PubMed Web of Science ®Google Scholar
• Schmidt , C. J. 1987 . Neurotoxicity of the psychedelic amphetamine, methylenedioxymethamphetamine . Journal of Pharmacology and Experimental Therapies , 240 ( 1 ) : 1 – 7 .
   PubMed Web of Science ®Google Scholar
• Schmidt , C. J. , Wu , L. and Lovenberg , W. 1986 . Methylenedioxymethamphetamine: A potentially neurotoxic amphetamine analogue . European Journal of Pharmacology , 124 ( 1–2 ) : 175 – 78 .
   PubMed Web of Science ®Google Scholar
• Schuster , P. , Lieb , R. , Lamertz , C. and Wittchen , H. U. 1998 . Is the use of Ecstasy and hallucinogens increasing? Results from a community study . European Addiction Research , 4 ( 1–2 ) : 75 – 82 .
   PubMed Web of Science ®Google Scholar
• Schwab , M. , Seyringer , E. , Brauer , R. B. , Hellinger , A. and Griese , E. U. 1999 . Fatal MDMA intoxication . Lancet , 353 ( 9152 ) : 593 – 94 .
   PubMedGoogle Scholar
• Semple , D. M. , Ebmeier , K. P. , Glabus , M. F. , O'Carroll , R. E. and Johnstone , E. C. 1999 . Reduced in vivo binding to the serotonin transporter in the cerebral cortex of MDMA (“Ecstasy”) users . British Journal of Psychiatry , 175 : 63 – 9 .
   PubMed Web of Science ®Google Scholar
• Sferios , E. 2001 . “ Minimizing risk in the dance community: An interview with Emanuel Sferios by Julie Holland. ” . In Ecstasy: The Complete Guide: A Comprehensive Look at the Risks and Benefits of MDMA. Edited by: Holland , J. Rochester, New York : Park Street Press. .
   Google Scholar
• Shankaran , M. , Yamamoto , B. and Gudelsky , G. 2001 . Ascorbic acid prevents 3,4-methylenedioxymethamphetamine (MDMA)-induced hydroxyl radical formation and the behavioral and neurochemical consequences of the depletion of brain 5-HT . Synapse , 40 ( 1 ) : 55 – 64 .
   PubMed Web of Science ®Google Scholar
• Shankaran , M. , Yamamoto , B. K. and Gudelsky , G. A. 1999 . Involvement of the serotonin transporter in the formation of hydroxyl radicals induced by 3,4-methylenedioxymethamphetamine . European Journal of Pharmacology , 385 ( 2–3 ) : 103 – 10 .
   PubMed Web of Science ®Google Scholar
• Sharkey , J. , McBean , D. E. and Kelly , P. A. 1991 . Alterations in hippocampal function following repeated exposure to the amphetamine derivative methylenedioxymethamphetamine (“Ecstasy”) . Psychopharmacology (Berlin) , 105 ( 1 ) : 113 – 18 .
   PubMed Web of Science ®Google Scholar
• Sherlock , K. , Wolff , K. , Hay , A. W. and Conner , M. 1999 . Analysis of illicit Ecstasy tablets: Implications for clinical management in the accident and emergency department . Journal of Accident and Emergency Medicine , 16 ( 3 ) : 194 – 97 .
   PubMedGoogle Scholar
• Shulgin , A. T. and Nichols , D. E. 1978 . “ Characterization of three new psychotomimetics. ” . In The Pharmacology of Hallucinogens. Edited by: Stillman , R. C. and Willette , R. E. New York : Pergamon. .
   Google Scholar
• Siegel , R. K. 1986 . MDMA: Nonmedical use and intoxication . Journal of Psychoactive Drugs , 18 ( 4 ) : 349 – 54 .
   PubMed Web of Science ®Google Scholar
• Solowij , N. , Hall , W. and Lee , N. 1992 . Recreational MDMA use in Sydney: A profile of “Ecstacy” users and their experiences with the drug . British Journal of Addiction , 87 ( 8 ) : 1161 – 72 .
   PubMedGoogle Scholar
• Sondermann , N. and Kovar , K. A. 1999 . Screening experiments of Ecstasy street samples using near infrared spectroscopy . Forensic Science International , 106 ( 3 ) : 147 – 56 .
   PubMed Web of Science ®Google Scholar
• Sprague , J. E. , Everman , S. L. and Nichols , D. E. 1998 . An integrated hypothesis for the serotonergic axonal loss induced by 3,4- methylenedioxymethamphetamine . Neurotoxicology , 19 ( 3 ) : 427 – 41 .
   PubMed Web of Science ®Google Scholar
• Suy , K. , Gijsenbergh , F. and Baute , L. 1999 . Emergency medical assistance during a mass gathering . European Journal of Emergency Medicine , 6 ( 3 ) : 249 – 54 .
   PubMedGoogle Scholar
• Topp , L. , Hando , J. , Dillon , P. , Roche , A. and Solowij , N. 1999 . Ecstasy use in Australia: Patterns of use and associated harm . Drug and Alcohol Dependence , 55 ( 1–2 ) : 105 – 15 .
   PubMed Web of Science ®Google Scholar
• Topp , L. and Mattick , R. P. 1997 . Choosing a cut-off on the Severity of Dependence Scale (SDS) for amphetamine users . Addiction , 92 ( 7 ) : 839 – 45 .
   PubMed Web of Science ®Google Scholar
• Tossmann , P. , Boldt , S. and Tensil , M. D. 2001 . The use of drugs within the techno party scene in European metropolitan cities . European Addiction Research , 7 ( 1 ) : 2 – 23 .
   PubMed Web of Science ®Google Scholar
• Trimbos Institute . 2000 . The Netherlands Drug Situation 2000: Report to the EMCDDA by the Redox National Focal Point of the Netherlands. Utrecht : Trimbos Institute. .
   Google Scholar
• Tuchtenhagen , F. , Daumann , J. , Norra , C. , Gobbelé , R. , Becker , S. , Pelz , S. , Sass , H. , Buchner , H. and Gouzoulis-Mayfrank , E. 2000 . High intensity dependence of auditory evoked dipole source activity indicates decreased serotonergic activity in abstinent Ecstasy (MDMA) users . Neuropsychopharmacology , 22 ( 6 ) : 608 – 17 .
   PubMed Web of Science ®Google Scholar
• Tucker , G. T. , Lennard , M. S. , Ellis , S. W. , Woods , H. F. , Cho , A. K. , Lin , L. Y. , Hiratsuka , A. , Schmitz , D. A. and Chu , T. Y. 1994 . The demethylenation of methylenedioxymethamphetamine (“Ecstasy”) by debrisoquine hydroxylase (CYP2D6) . Biochemical Pharmacology , 41 ( 7 ) : 1151 – 56 .
   Google Scholar
• van de Wijngaart , G. F. , Braam , R. , de Bruin , D. , Fris , M. , Maalste , N. J.M. and Verbraeck , H. T. 1999 . Ecstasy use at large-scale dance events in the Netherlands . Journal of Drug Issues , 29 ( 3 ) : 679 – 702 .
   Web of Science ®Google Scholar
• Vargas-Rivera , J. , Ortega-Corona , B. G. , Garcia-Pineda , J. , Carranza , J. , Salazar , L. A. and Villarreal , J. 1990 . Influence of previous housing history on the toxicity of amphetamine in aggregate mice . Archives of Investigative Medicine (Mexico) , 21 ( 1 ) : 65 – 9 .
   PubMedGoogle Scholar
• Verkes , R. J. , Gijsman , H. J. , Pieters , M. S.M. , Schoemaker , R. C. , de Visser , S. , Kuijpers , M. , Pennings , E. J.M. , de Bruin , E. , Van de Wijngaart , G. , Van Gerven , J. M.A. and Cohen , A. F. 2001 . Cognitive performance and serotonergic function in users of Ecstasy . Psychopharmacology (Berlin) , 153 ( 2 ) : 196 – 202 .
   PubMed Web of Science ®Google Scholar
• Vollenweider , F. X. , Gamma , A. , Liechti , M. and Huber , T. 1998 . Psychological and cardiovascular effects and short-term sequelae of MDMA (“Ecstasy”) in MDMA-naive healthy volunteers . Neuropsychopharmacology , 19 ( 4 ) : 241 – 51 .
   PubMed Web of Science ®Google Scholar
• von Sydow , K. , Lieb , R. , Pfister , H. , Hofler , M. and Wittchen , H.-U. 2002 . Use, abuse and dependence of Ecstasy and related drugs in adolescents and young adults: A transient phenomenon? Results from a longitudinal community study . Drug and Alcohol Dependence , 66 : 147 – 59 .
   PubMed Web of Science ®Google Scholar
• Wallace , T. L. , Gudelsky , G. A. and Vorhees , C. V. 2001 . Alterations in diurnal and nocturnal locomotor activity in rats treated with a monoamine-depleting regimen of methamphetamine or 3,4-methylenedioxymethamphetamine . Psychopharmacology (Berlin) , 153 ( 3 ) : 321 – 26 .
   PubMed Web of Science ®Google Scholar
• Wareing , M. , Fisk , J. E. and Murphy , P. N. 2000 . Working memory deficits in current and previous users of MDMA (“Ecstasy”) . British Journal of Psychology , 9 ( Pt 2 ) : 181 – 88 .
   Google Scholar
• Williams , H. , Dratcu , L. , Taylor , R. , Roberts , M. and Oyefeso , A. 1998 . “Saturday Night Fever”: Ecstasy related problems in a London accident and emergency department . Journal of Accident and Emergency Medicine , 15 ( 5 ) : 322 – 26 .
   PubMedGoogle Scholar
• Winstock , A. R. , Griffiths , P. and Stewart , D. 2001 . Drugs and the dance music scene: A survey of current drug use patterns among a sample of dance music enthusiasts in the UK . Drug and Alcohol Dependence , 64 ( 1 ) : 9 – 17 .
   PubMed Web of Science ®Google Scholar
• Winstock , A. R. , Wolff , K. and Ramsey , J. 2001 . Ecstasy pill testing: harm minimization gone too far? . Addiction , 96 ( 8 ) : 1139 – 48 .
   PubMed Web of Science ®Google Scholar
• Wu , D. , Otton , S. V. , Inaba , T. , Kalow , W. and Sellers , E. M. 1997 . Interactions of amphetamine analogs with human liver CYP2D6 . Biochemical Pharmacology , 53 ( 11 ) : 1605 – 12 .
   PubMed Web of Science ®Google Scholar